Expanding minority and growth investing
Advent appears to be broadening its investment approach to include more thematic minority stakes and growth‑stage capital alongside its traditional control‑oriented buyouts.
Public filings and announcements show a series of recent transactions that span majority acquisitions, minority investments and large primary growth rounds across sectors such as AI, healthcare, aerospace and business software.
-
Advent co‑led Vinci's $250 million Series B at a $1.5 billion valuation, adding a large growth investment in frontier AI and AI‑native hardware engineering infrastructure.
-
Advent's NZCR acquisition was backed by NZ$300 million of financing and is framed around expanding capabilities, sponsor relationships, and international reach.
-
Devoted Health closed $555 million of Series G primary funding led by Advent, with investors also committing $622 million for a shareholder tender offer.
-
Advent announced a definitive agreement to acquire a majority stake in CONTPAQi, a Mexican business‑software provider for SMBs.
Points the other way · adventinternational.com
-
Advent completed its €109.4 million investment in Avio through a reserved capital increase, resulting in a post‑money stake of about 6.54 %.